Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Martin Glas, Gerrit H. Gielen et al.|Journal of Translational Medicine|2019Cited by 78
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Oliver Brüstle et al.|Clinical Cancer Research|2016Cited by 72
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastomaLaurèl Rauschenbach, Björn Scheffler, Anja Wieland et al.|European Journal of Cancer|2020Cited by 22
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Clinical Cancer Research|2022Cited by 4
Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0